Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

Novo Nordisk will discontinue Human Mixtard, a top-selling insulin in India. This decision aligns with the company's global ...

New research found hospital visits from Ozempic and Wegovy are rare, but can be serious. Experts explain the finding and ...

In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, ...

The maker of Ozempic and Wegovy found fake 1-milligram injections were being distributed through unauthorized sellers.

Discover Mounjaro Tirzepatide's impact on obesity in India post its March launch. Get insights on effectiveness against diabetes, hypertension & more.

Ozempic and Mounjaro generated similar results ... than peptides and does not require packaging in special injection pens. It does not have to be kept refrigerated. For now the drugs are only ...

Patients on the new pill also lost weight — up to 16 pounds without reaching a plateau at the study’s end. Side effects were ...

T he US Food and Drug Administration (FDA) and pharmaceutical company Novo Nordisk are now in an attempt to making more ...

WEIGHT loss injections have become the holy grail in the fight against obesity, helping people shift the pounds they’ve been ...

But these drugs do expire after a few weeks, and microdosing could increase the risk of inadvertently using them after their ...